搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
money.rediff
10 天
Lupin Gets USFDA Nod for Generic HIV Drug
Lupin has received USFDA approval for its generic version of Symtuza, a medication for HIV. The product is estimated to have ...
10 天
on MSN
Drug firm Lupin gets USFDA nod for generic HIV medication
The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily ...
21 分钟
on MSN
Pharma stocks in focus after medicine tariff changes in Union Budget 2025
Finance Minister Sitharaman announced the inclusion of six life-saving drugs in the concessional 5% duty slab to enhance ...
GlobalData on MSN
9 天
FDA approves drug application for Lupin’s heart failure therapy
The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.
Managed Healthcare Executive
9 天
Lupin's Generic HIV Treatment for Children Receives Tentative FDA Approval
This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...
6 天
Lupin and Avas Launch NaMuscla® in Italy
Lupin and Avas Launch NaMuscla® in Italy Enables expanded access to the only EU-approved treatment for the myotonia symptoms ...
Daily
5 天
Lupin, Avas unveil myotonia treatment NaMuscla in Italy
Mumbai: Global pharma major Lupin Limited and Avas Pharmaceuticals SRL have announced the launch of Lupin's orphan drug ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈